GLSHQ — Gelesis Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $65.64m
- $25.77m
Annual cashflow statement for Gelesis Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -25.9 | -93.3 | -55.8 |
| Depreciation | |||
| Amortisation | |||
| Deferred Taxes | |||
| Non-Cash Items | 5.34 | 14.9 | -33.5 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -6.01 | 19.4 | 6.07 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -22 | -55.3 | -77.7 |
| Capital Expenditures | -32.2 | -19.9 | -9.12 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -24 | 24 | 0 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -56.2 | 4.08 | -9.12 |
| Financing Cash Flow Items | 11.3 | 0 | 70.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 88.9 | 32.5 | 66.3 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 12.4 | -19.7 | -21 |